氢能催化剂

Search documents
凯立新材(688269):医药、基础化工销量高增,25Q2盈利能力显著回升
Shanxi Securities· 2025-08-25 07:24
资料来源:最闻 公司近一年市场表现 | 市场数据:2025 年 8 月 | 22 日 | | | --- | --- | --- | | 收盘价(元): | | 39.96 | | 年内最高/最低(元): | | 41.01/20.86 | | 流通A股/总股本(亿): | | 1.31/1.31 | | 流通 A 股市值(亿): | | 52.23 | | 总市值(亿): | | 52.23 | | 基础数据:2025 年 | 6 月 | 30 日 | | | --- | --- | --- | --- | | 基本每股收益(元): | | | 0.47 | | 摊薄每股收益(元): | | | 0.47 | | 每股净资产(元): | | | 8.03 | | 净资产收益率(%): | | | 5.82 | 冀泳洁 博士 执业登记编码:S0760523120002 邮箱:jiyongjie@sxzq.com 王锐 执业登记编码:S0760524090001 邮箱:wangrui1@sxzq.com 研究助理: 申向阳 邮箱:shenxiangyang@sxzq.com 新材料 凯立新材(688269.SH ...
凯立新材(688269):放量继续 静待重估
Xin Lang Cai Jing· 2025-08-17 06:31
Core Viewpoint - The company reported strong financial performance in H1 2025, driven by increased sales of catalyst products and structural changes in its business model [1] Group 1: Financial Performance - In H1 2025, the company achieved revenue, net profit attributable to shareholders, and net profit excluding non-recurring gains and losses of 1.014 billion, 61 million, and 63 million yuan respectively, representing year-on-year increases of 24.86%, 30.83%, and 48.74% [1] - In Q2 2025, the company recorded revenue, net profit attributable to shareholders, and net profit excluding non-recurring gains and losses of 389 million, 39 million, and 40 million yuan respectively, with year-on-year changes of -23.42%, +11.38%, and +15.47% [1] Group 2: Business Segments - The sales volume in the basic chemical sector increased by 185.5% year-on-year, primarily due to a 113.2% increase in sales of mercury-free PVC catalysts, along with the introduction of multiple basic chemical catalysts to the market [1] - The pharmaceutical segment saw a sales increase of 49.3% year-on-year, driven by increased demand from core customers and an improvement in market share [1] - The environmental and new energy segment experienced a staggering 1497.1% increase in sales year-on-year, attributed to significant progress in hydrogen catalysts and partnerships with leading companies in water electrolysis hydrogen production [1] Group 3: Future Outlook - The company is expected to maintain an upward trend in its fundamentals, with significant breakthroughs in key customer orders for PVC products anticipated in the second half of 2024 [2] - The company has a backlog of 461 tons of orders for PVC products as of the end of Q1 2025, which is expected to support high growth in sales and revenue for the basic chemical sector throughout the year [2] - The HNBR (hydrogenated nitrile butadiene rubber) industrialization project is expected to launch in the second half of 2025, which could lead to a significant improvement in production efficiency and product quality, positioning the company as a leader in the domestic high-end HNBR market [2] Group 4: Profit Forecast and Investment Recommendation - The company is projected to achieve net profits attributable to shareholders of 170 million, 236 million, and 268 million yuan for 2025-2027, representing year-on-year growth rates of 83.51%, 38.66%, and 13.67% respectively [3] - The current price-to-earnings ratios corresponding to these profit forecasts are 30.8, 22.2, and 19.5 times [3] - The company is expected to exhibit strong performance due to rising prices of key raw materials, increased production in the basic chemical sector, and a recovery in the pharmaceutical sector, leading to a favorable profit growth outlook [3]